key: cord-1041097-qe1subjo
authors: Ramachandran, Karthik; Maity, Soumya; Muthukumar, Alagar R.; Kandala, Soundarya; Tomar, Dhanendra; Abd El-Aziz, Tarek Mohamed; Allen, Cristel; Sun, Yuyang; Venkatesan, Manigandan; Madaris, Travis R.; Chiem, Kevin; Truitt, Rachel; Vishnu, Neelanjan; Aune, Gregory; Anderson, Allen; Martinez, Luis; Yang, Wenli; Stockand, James D.; Singh, Brij B.; Srikantan, Subramanya; Reeves, W. Brian; Madesh, Muniswamy
title: SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics
date: 2022-01-01
journal: iScience
DOI: 10.1016/j.isci.2021.103722
sha: ce1120fb3a2f8f55ef8fd0632e68648a42efa7e2
doc_id: 1041097
cord_uid: qe1subjo

SARS-CoV-2 is a newly identified coronavirus that causes the respiratory disease called coronavirus disease 2019 (COVID-19). With an urgent need for therapeutics, we lack a full understanding of the molecular basis of SARS-CoV-2-induced cellular damage and disease progression. Here, we conducted transcriptomic analysis of human PBMCs, identified significant changes in mitochondrial, ion channel, and protein quality-control gene products. SARS-CoV-2 proteins selectively target cellular organelle compartments, including the endoplasmic reticulum and mitochondria. M-protein, NSP6, ORF3A, ORF9C, and ORF10 bind to mitochondrial PTP complex components cyclophilin D, SPG-7, ANT, ATP synthase and a previously undescribed CCDC58 (Coiled-coil domain containing protein 58). Knockdown of CCDC58 or mPTP blocker cyclosporin A pretreatment enhances mitochondrial Ca2+ retention capacity and bioenergetics. SARS-CoV-2 infection exacerbates cardiomyocyte autophagy and promotes cell death that was suppressed by cyclosporin A treatment. Our findings reveal that SARS-CoV-2 viral proteins suppress cardiomyocyte mitochondrial function that disrupts cardiomyocyte Ca2+ cycling and cell viability.

Although several million people worldwide have been infected with coronavirus-SARS-CoV-2, the causative agent of the COVID-19 pandemic, our understanding of the fundamental mechanisms underlying the clinical manifestation of COVID-19 is still emerging. The SARS-CoV-2 entry receptor, ACE2 is highly expressed in several cell types, including myocardial cells, kidney proximal tubule cells, type II alveolar cells, and lymphocytes located in oral mucosa and other tissues. Beyond this canonical entry pathway, the mechanisms of cellular damage and tissue injury are poorly understood but are of paramount importance. Although the virus commonly causes respiratory distress, ≈33% of patients exhibit clinical or laboratory evidence of myocardial injury as. Myocardial injury is especially common in COVID-19 patients with a history of cardiovascular disease (30-60%). A deeper understanding of the mechanisms underlying myocardial injury is needed to develop a therapeutic strategy for such patients with co-morbidities.

Diverse viruses, including influenza M2, HIV-1, and coronavirus E, can undermine the cellular ion homeostasis machinery to allow viral entry and replication, either by co-opting the host ion channels' ability to maintain membrane potential (Fujioka et al., 2018; Hover et al., 2017) or by forming ion channels of virally encoded short membrane proteins which oligomerize to form hydrophilic pores that facilitate ion transport across host cell membranes and override the cellular homeostatic circuits (Wang et al., 2011) . However, it is unknown whether SARS-CoV-2 adopts similar mechanistic routes. Among ion channels, the host Ca 2+ channels influence every process of viral infection and viruses usurp host Ca 2+ channels to disturb the homeostatic balance in such a way to benefit the virus lifecycle at the cost of host survival. For example, Influenza A virus infection is initiated by the interaction of the viral glycoprotein hemagglutinin with the voltage-dependent Ca 2+ channel Cav1.2 to trigger intracellular Ca 2+ oscillations and subsequent viral entry and replication (Fujioka et al., 2018) . Importantly, in cardiac muscle, Ca 2+ influx is also mediated through the L-type Ca 2+ channel, suggesting that alterations of voltage gated calcium channels could be an important factor in COVID-19 and myocardial injury. Inhibition of store-operated Ca 2+ channel activity reduced the viral egress, and thus infectivity, of many enveloped RNA viruses (Chen et al., 2019; Han et al., 2015) . This is evidenced by recent repurposing of existing drugs to treat SARS-CoV-2 infection (Gordon et al., 2020b) . Specifically, pharmacological agents targeting Sigma1 receptors, known to activate IP3R-dependent Ca 2+ efflux (via store-operated channels) from the ER (Gordon et al., 2020a) , showed activity against SARS-CoV-2 infection. We have recently reported that HIV-1 Nef-mediated inhibition of cellular protein quality control is one possible mechanism involved in the development of HIV-associated cardiomyopathy and progression towards heart failure (Cheung et al., 2019; Gupta et al., 2017; Muthumani et al., 2006; Natarajaseenivasan et al., 2018; Tahrir et al., 2018) . Our recent molecular characterization of the mitochondrial permeability transition pore (PTP) revealed that viral proteins, bacterial toxins, and ion dysregulation elicit PTP and induce cardiac cell death (Shanmughapriya et al., 2015b) . Interestingly, a new report revealed that SPG7 is upregulated upon SARS-CoV-2 infection (Bojkova et al., 2020b) , suggesting a role of PTP-mediated mitochondrial dysfunction in determining COVID-19 development and associated myocardial injury.

Although much work has focused on innate and adaptive immune dysregulation in the pathophysiology of COVID-19, the effect of SARS-CoV-2 infection on cellular metabolic activity is unknown. Here we deliver findings that reveal how viral proteins hijack intracellular organelles, ion channels, bioenergetics, and quality control. Our unbiased RNA-Seq analysis of uninfected individuals, patients tested positive for SARS-CoV-2 with asymptomatic, and severely affected COVID-19 patients reveal numerous human transcripts either upregulated or suppressed in the severely affected COVID-19 patients when compared to counterparts. Intriguingly, mitochondrial DNA encoded transcripts were markedly suppressed, while nuclear encoded mitochondrial respiratory complex, mitochondrial permeability transition pore (mPTP), and mitophagy related transcripts were markedly elevated in severely affected COVID-19 patients. These severely affected COVID-19 patients showed elevated levels of troponin-C and IL-6 in the plasma. Having observed the elevated cardiac injury marker in COVID-19 samples, we utilized iPSCderived human cardiomyocytes (iPSC-CM) to explore the host molecular pathways targeted by SARS-CoV-2 viral proteins. Although SARS-CoV-2 encodes 28 gene products, our comprehensive targeted analyses demonstrate that the viral structural protein, Membrane (M), along with NSP6, NSP10, ORF3a, and ORF9c proteins discretely localize to either mitochondria, endoplasmic reticulum, or plasma membrane compartments. Reconstitution of M-protein in iPSC-CMs markedly inhibited CaV1.2 channel currents. Moreover, ectopic expression of M-protein in human cells resulted in mitochondrial swelling, possibly through the strong interaction with mitochondrial permeability transition pore components SPG7 and CCDC58 to enhance pore opening and causing mitochondrial dysfunction.

To understand the global transcriptional regulation of human mRNAs upon SARS-CoV-2 infection, we utilized PBMCs obtained from 1) uninfected individuals, 2) SARS-CoV-2 positive patients with mild symptoms, and 3) SARS-CoV-2 positive patients who were admitted to the intensive care unit at the University of Texas Southwestern Dallas (UTSW) (IRB Protocol number STU-2020-0366) ( Table S1 ). The RBC contamination in the blood samples was eliminated by routine RBC lysis protocol followed by PBMC purification and total RNA isolation. Total RNA was isolated using the BSL-3 facility at Texas Biomedical Research Institute (TBRI) followed by RNA quantification. Total RNA isolated from PBMCs was depleted of rRNA and globin and used for library construction (NEBNext Ultra RNA Library Prep Kit). The sequencing libraries were multiplexed and sequenced on the Illumina HiSeq instrument using a 2x150 paired-end (PE) configuration. Image analysis and base calling are conducted by the HiSeq Control Software (HCS). Raw sequence data (.bcl files) generated from Illumina HiSeq were converted into fastq files and de-multiplexed using Illumina's bcl2fastq 2.17 software. One mismatch is allowed for index sequence identification. Using DESeq2, a comparison of gene expression between the groups of samples were performed at GENEWIZ® (GENEWIZ, South Plainfield, NJ). Using this comprehensive data, we generated a heatmap that depicts the segregation of elevated vs down regulated RNA transcripts of PBMCs ( Figure 1A) . A principal component analysis (PCA) was performed using the "plot PCA" function within the DESeq2 R package (Table S2 ). Although the sample size was small, the dynamism of RNA clustering is tight in SARS-CoV-2 infected samples indicating that host cellular transcriptome changes were controlled by the virus ( Figure 1B ). These RNA transcripts were assessed, and distribution of individual subjects were plotted ( Figure 1C ). The GO analysis was used to functionally cluster the set of genes based on their biological process and determine their statistical significance ( Figure 1D ; Table S2 ). Although our data included both sexes, the severely affected human subjects were male that possibly could have an influence on the differential gene expression among groups (Table S1 and S2). Using this computational analysis, we focused on the highly significantly altered RNA transcripts induced upon viral infection. We found that mitochondrial energetic complex components, ion channel subunits, and autophagy and mitophagy regulated translational precursors were markedly altered and thus focused on our studies ( Figure 1E ). Intriguingly, the severely affected COVID-19 patient samples showed elevated cardiac injury markers such as troponin-C, proBNP, and LDH suggesting acute cardiac damage manifestation in these patients ( Figure 1F ).

Having observed a cardiac stress marker elevation in severely affected COVID-19 patients, we next tested whether SARS-CoV-2 infection causes cardiomyocyte damage. We utilized human-iPSC-derived cardiomyocytes as a surrogate model system to determine the severity of SARS-CoV-2 infection. To determine the mitochondrial changes, we expressed Ad-mito-GCamp6 or stained with MitoTracker Red as mitochondrial markers. Upon SARS-CoV-2 infection, we found that mitochondrial shape change and fragmentation were evident in virus-infected cardiomyocytes indicating that the viral proteins possibly target mitochondria and impact bioenergetics (Figure 2A and 2B). Based on prediction algorithms and proteomic analysis (Gordon et al., 2020a) , we cloned and expressed mRFP/Flag-tagged 13 of the 29 SARS-CoV-2 proteins in COS-7 cells to monitor their cellular distribution and localization. Since these individual candidate genes were tagged with FLAG, we transiently transfected in COS-7 cells and high-level ectopic protein expression was confirmed by Western blotting (Figure 2C ). Highresolution imaging of the SARS-CoV-2 proteins was performed using the mRFP-tag in live cells loaded with ER tracker and mitochondrial marker (DHR123) to determine the spatial overlap and intensity profiles ( Figure S1 ). The imaging results show that four of these proteins, Orf9C, M-protein, Nsp6, and Orf3a, were localized to either ER or mitochondrial membranes (Figure S1A and S1B and Figure 2D -2H). In particular, Mprotein was predominantly localized in the mitochondrial compartment ( Figure 2D and 2H) Remarkably, Nsp7 exhibited ER remodelling and transmigrated near the plasma membrane ( Figure 2F ). While assessing their host cellular distribution, we observed that M-protein expression induced mitochondrial morphological changes ( Figure 2D and 2I). These results indicate that the replication and structural SARS-CoV-2 proteins reside in host cellular organelles besides their canonical function.

The RNA profiling analysis showed that both nuclear and mitochondrial genome encoded transcripts were markedly altered in PBMCs from severely affected COVID-19 patients ( Figure 3A ; Table S2 ). Since severely affected COVID-19 patient outcomes include organ failure and death, we focused on candidate genes that promote cell death and mitochondrial dysfunction. Of these transcripts, the previously uncharacterized CCDC58 was significantly elevated in PBMCs obtained from COVID-19 patients ( Figure 3B ). Based on the mitoCarta and Mito-miner database, CCDC58 is predicted to target mitochondrial compartment (Pagliarini et al., 2008) . To assess its localization, C-terminal FLAG-tagged CCDC58 was co-transfected with the mitochondrial marker protein COX8A-mRFP. As predicted, immunoflurescence analysis confirmed that CCDC58 localized predominantly to mitochondria and exhibited near complete overlap with COX8A ( Figure 3C and 3D; Figure S2A and S2B). It has been reported that high throughput RNAi-mediated silencing of mitochondrial resident proteins, including CCDC58, results in increased mitochodnrial Ca 2+ retention capacity suggesting a link between mitochondrial Ca 2+ overload and cell death (Shanmughapriya et al., 2015a) . Therefore, we determined if stable knockdown of CCDC58 produces resistance to Ca 2+ -induced mitochondrial permeability transition pore opening. The stable transfected control (NegshRNA) and CCDC58 KD 293T cells were subjected to permeabilization using digitonin containing intracellular medium (ICM). Upon exposure to excessive extramitochondrial Ca 2+ , control cells exhibited rapid mitochondrial membrane potential (m) loss due to Ca 2+ -induced PTP opening ( Figure 3E and Figure  S3 ). In contrast, knockdown of CCDC58 markedly increased mitochondrial Ca 2+ retention capacity ( Figure 3D and 3F). Additionally, CCDC58 KD cells exhibited higher OCR but cellular ATP levels ( Figure S4A -S4H). CCDC58 KD cells exposed to oxidants still partially retained Calcein indicating that CCDC58 likely participates in mPTP complex ( Figure S4I -S4J). Having observed an elevation of CCDC58 under COVID-19 disease development, we next asked whether SARS-CoV-2 M-protein targets CCDC58 protein to alter mitochondrial function. To test this, we reconstituted M-protein in CCDC58 KD cells and monitored CRC. Remarkably, cells lacking CCDC58 were able to maintain CRC when compared to control cells, highlighting a critical role for CCDC58 in COVID-19 induced mitochodnrial dysfunction ( Figure 3G and 3H).

Having observed a robust elevation of CCDC58 in COVID-19 patients and Ca 2+ dependent functional changes of mitochondrial energetics, we sought to identify SARS-CoV-2 proteins that bind to SPG7 in the mitochondria. We utilized C-terminal hemagglutinin (HA)-tagged cyclophilin D (PPIF) or SPG7 and FLAG-tagged 13 genes of SARS-CoV-2. Transfection of COS-7 cells with these tagged proteins showed substantial ectopic expression ( Figure 4A and 4B and Figure S5A ). These individual genes were transiently co-transfected with cyclophilin D or SPG-7 in COS-7 cells, and cell lysates were subjected to immunopurification with HA antibody to identify the protein complexes. HA-tagged SPG-7 was immunoprecipitated with NSP6, M-protein, ORF3a, ORF9b, ORF9c, and ORF10 ( Figure 4A and 4B and Figure S5A ). While, cyclophilin D interacts with NSP6, M-protein, ORF3A, ORF9b, and ORF10 ( Figure 4A ). Next, we used CCDC58 as a bait. C-terminal Myc-tagged CCDC58 was cotransfected with the FLAG-tagged 13 viral proteins in COS-7 cells ( Figure 4C ). Remarkably, NSP6, M-protein, ORF3A, ORF9c, ORF9b, and ORF10 were pulled down using an antibody specific for Myc (CCDC58) ( Figure 4C ). We have also confirmed these interactions by reverse IP as well as endogenous mPTP complex interactions ( Figure S5B and S5C). Since knockdown of CCDC58 resulted in increased mitochondrial Ca 2+ retention capacity, we next tested whether PPIF and SPG7 interact with CCDC58. COS-7 cells were cotransfected with either CCDC58/PPIF or CCDC58/SPG7 plasmids ( Figure 4D and Figure S5A ). Remarkably, ectopic reconstitution of CCDC58 in COS-7 cells showed a strong interaction with SPG7 and PPIF indicating that CCDC58 interacts with SPG7 due to its localization in the mitochondrial intermembrane space ( Figure 4D and Figure S5A ). Additionally, we have examined the SARS-CoV-2 proteins interaction with ANT and ATP synthase (Alavian et al., 2014; Bonora et al., 2013; Giorgio et al., 2013; Karch et al., 2019; Shanmughapriya et al., 2015a; Zhou et al., 2019) . SARS-Cov-2 plasmids were ectopically expressed in COS-7 cells and immunoprecipitated for SPG7, ANT, ATP synthase binding ( Figure 4E ). Invariably, SARS-CoV-2 proteins interacts with human mPTP complex components ( Figure 4E ). Collectively, these results indicate SARS-CoV-2 proteins target multiple organelles, particularly mitochondria, which selectively interact with mPTP complex components ( Figure 4F ).

J o u r n a l P r e -p r o o f

We again performed a reductionist approach to determine whether these mitochondrial functional changes result in aberrant organelle quality control upon SARS-CoV-2 infection. Our targeted transcriptomic analysis showed that autophagy/mitophagy markers were significantly elevated in PBMCs derived from severely affected COVID-19 patients ( Figure 5A ; Table S2 ). We next asked whether SARS-CoV-2 viral infection reorganizes cytoskeletal apparatus and ER network in human-iPSC-derived cardiomyocytes. Cardiomyocytes were ectopically coexpressed tubulin-GFP and Sec61b-mCherry adenoviral constructs (AdV5a) and architecture was visualized using confocal imaging. As expected, myocytes displayed choreographed cytoskeletal and ER compartments ( Figure 5B ). Upon SARS-CoV-2 infection for 24 hours, both cytoskeletal and ER reticular network were collapsed ( Figure 5C ). Having observed, the live SARS-CoV-2 virus cause cellular stress, we next assessed the effect of virus on the cellular quality control mechanism. Autophagy is a dynamic phenomenon involving autophagosome formation, autophagosome/lysosome fusion and clearance by lysosomes. To assess whether autophagy was impacted by viral infection, we monitored autophagic flux in cardiomyocytes after SARS-CoV-2 infection using adenovirus expressing a tandem LC3 (light chain 3)-GFP (green fluorescent protein)-RFP (red fluorescent protein) reporter that enables the detection of the autophagic flux process ( Figure 5D ). Green puncta indicate autophagosome formation, while red puncta indicate autophagolysosome formation. In the acidic environment of lysosomes, the GFP signal is quenched. Under basal culture conditions, we observed nominal levels of LC3 puncta in both compartments, while cardiomyocytes infected with SARS-CoV-2 for 24 hrs elicited massive number of positive autophagic vesicles ( Figure 5D and 5E). These data suggest that viral infection exacerbates autophagic flux that possibly eliminates a large number of dysfunctional mitochondria.

We next tested whether viral proteins alter mitochondrial bioenergetics and possibly induce cardiomyocyte cell death. The mitochondrial oxygen consumption rate (OCR) in HEK293 cells overexpressing viral proteins was measured. Remarkably, cells expressing M-protein or ORF3a had lower basal OCR and minimal FCCP-induced maximal OCR ( Figure 6A ). Interestingly, NSP6 and NSP7 exhibited a partial suppression of maximal OCR ( Figure 6A ). However, the ECAR (extracellular acidification rate) was similar among these cell types ( Figure 6B ). Although OCR was affected by these viral proteins, the cells were viable, indicating a switch from oxidative to glycolytic phenotypes. To further investigate the impact of viral proteins on mitochondrial ion homeostasis, we measured MCU channel activity as well as mitochondrial CRC in the permeabilized cell system. We found that the CRC is reduced by ectopic expression of SARS-CoV-2 proteins, however the MCU activity remains intact ( Figure 6C -6E and Figure S6 ). We next evaluated whether mPTP blocker cyclosporin A restores the CRC in viral protein expressing condition. As expected CsA enhanced the mitochondrial CRC, but the viral M-protein mediated CRC reduction was still observed ( Figure 6C and 6D; Figure S6 ). Reconstitution of these viral proteins exhibited lower CRC with the exception of NSP7 ( Figure 6E ). Finally, we assessed the cardiomyocyte viability under viral infection. 24 hours postinfection, cardiomyocyte viability was assessed using MTT assay ( Figure 6F ). J o u r n a l P r e -p r o o f Cardiomyocytes exposed to virus exhibited a significant cell death that was considerably prevented by cyclosporin A treatment suggesting that these viral particle/proteins could disrupt mitochondrial bioenergetics through mPTP opening and eventual cardiomyocyte damage ( Figure 6F ).

The RNA-Seq analysis from the severely affected patients revealed a significant elevation of Ca 2+ channel component transcripts, in particular, LTCC (CACNA1C) and the CRAC channel regulator, STIM1, were upregulated ( Figure 1 ). Having shown that SARS-CoV2 infection alters the expression of ion channels in cardiomyocytes, we next determined the impact of SARS-CoV-2 on cardiomyocyte function using hiPSC-CMs. We first determined the effect of SARS-CoV-2 infection on RNA transcript changes in human iPSC derived cardiomyocytes (hiPSC-CM). hiPSCs-CMs were developed as described previously and infected with SARS-CoV-2 virus for 24 hours. Importantly, the targeted RNA-Seq analysis exhibited a significant alteration of ion channels transcripts, in particular Ca 2+ channels (LTCC subunits, TRP, IP3R, and MCU) were elevated in SARS-CoV-2 infected hiPSC-CMs ( Fig. 7A-7D ; Tables S3 and S4) (Baughman et al., 2011; Csordas et al., 2013; De Stefani et al., 2011; Dong et al., 2017; Kirichok et al., 2004; Mallilankaraman et al., 2012a; Mallilankaraman et al., 2012b; Pan et al., 2013) . Conversely, the CRAC channel, Orai3, and mitochondrial Mg 2+ uptake channel Mrs2 were suppressed ( Fig. 7D ) . Since efficient Ca 2+ cycling is essential for cardiomyocyte contraction and relaxation, we first tested the spontaneous Ca 2+ cycling in hiPSC-CMs. A robust Ca 2+ cycling was observed in control hiPSC-CMs, but this rhythmic Ca 2+ cycling was perturbed in hiPSC-CMs expressing SARS-CoV-2 Mprotein ( Figure 7E ). Although the Ca 2+ amplitude was similar, the diastolic concentrations and frequencies of systolic Ca 2+ were markedly prolonged in hiPSC-CMs expressing SARS-CoV-2 M-protein ( Figure 7E and 7F). Similarly, overexpression of NSP-6 exhibited dramatic disruption in both amplitude and Ca 2+ cycling ( Figure 7E and 7F) indicating that impairment of cardiomyocytes Ca 2+ cycling by viral proteins could alter force generation. Functional characterization (using whole-cell configuration at various membrane potential) further showed the presence of L-type Ca 2+ currents in control hiPSC-CMs ( Figure 7G ). Importantly, the hiPSC-CMs displayed I/V properties and inhibition by nifedipine typical for Cav1.2 channels (LTCC) (Bers, 2002 (Bers, , 2008 (Bers, , 2014 Catterall et al., 2005) ( Figure 7G ). Having observed a perturbation of Ca 2+ cycling, we ectopically expressed SARS-CoV-2 M-protein, ORF-9c, ORF-3a, NSP-6, and NSP-7 in hiPSC-CMs. These viral proteins resulted in significant suppression of Cav1.2 currents ( Figure 7H ). Collectively these results reveal that SARS-CoV-2 viral proteins disrupt cardiomyocyte Ca 2+ cycling and ion channel activity.

Numerous studies have shown a large percentage of individuals diagnosed with COVID-19 manifest evidence of myocardial injury and that these individuals have a higher risk of death (Calvo-Fernández et al., 2020) . The SARS-CoV-2 Spike protein binds to its cellular receptor, the ACE2 protein and TMPRSS2, to enter host cells (Hoffmann et al., 2020) . ACE2 is highly expressed on cardiomyocytes (Han et al., 2020) and direct infection of cardiomyocytes by SARS-CoV-2 has been documented in patients (Tavazzi et al., 2020; Tian et al., 2020) and in cultured cardiomyocytes (Wong et al., 2020) . However, the mechanisms by which the virus alters cardiomyocyte function remain unclear. To better delineate the pathways perturbed during SARS-CoV-2 infection, we performed RNASeq analysis of PBMCs from COVID-19 patients. Furthermore, we performed detailed molecular and biochemical studies of human-iPSC-derived cardiomyocytes. In addition, we also characterized cellular organelle (ER and mitochondria) morphological changes upon cellular targeting by SARS-CoV-2 viral proteins in different cell model systems.

First, we determined the global transcriptome profile of SARS-CoV-2 infection in PBMCs obtained from healthy volunteers, symptomatic, and severely affected COVID-19 patients. Pathways which were significantly altered in COVID-19 patients with severe illness included transcription, mitochondrial oxidative phosphorylation, ATP biosynthesis, ion channels, autophagy, and apoptosis ( Figure. 1 and 3) . Likewise, oxidative phosphorylation, calcium signaling, and apoptosis have been reported by other groups to be altered in COVID-19 PBMCs (Gardinassi et al., 2020; Xiong et al., 2020) . This remarkable regulation suggests that SARS-CoV-2 proteins are not only essential for viral replication, assembly, and cell lysis, but also potentially target host cellular compartments to affect cell and organ function. Based on predictions of SARS-CoV-2 protein structure (Gordon et al., 2020b) , we selected 13 viral proteins for further analysis. Of these, we found that several were localized to ER, mitochondria, and/or plasma membrane. We also observed that these viral proteins resulted in dramatic changes in mitochondrial morphology ( Figure 2 ) and mitochondrial function. These findings emphasize that SARS-CoV-2 proteins have a moonlighting role beside their canonical functions.

Having noted transcriptomic changes associated with oxidative phosphorylation and localization of SARS-CoV-2 proteins to mitochondria, we focused our attention on mitochondrial proteins. Of these, we found a significant elevation of a previously uncharacterized nuclear encoded mitochondrial protein, CCDC58, in COVID-19 PBMCs ( Figure 3A and 3B). A recent report also identified an upregulation of mPTP complex components SPG7 and cyclophilin D in Caco-2 cells infected with SARS-Co-V-2 (Bojkova et al., 2020a; Shanmughapriya et al., 2015a; Zhou et al., 2019) . Therefore, we explored the role of CCDC58 in the mPTP. We confirmed that CCD58 is localized to the mitochondria ( Figure 3C ) and showed that knockdown of CCDC58 dramatically enhanced the capacity of mitochondria to sequester calcium. Of interest, expression of the SARS-CoV-2 M protein reduced calcium sequestration in the absence of CCDC58. We then performed a systematic assessment of interactions between SARS-CoV-2 proteins and components of the mPTP. Indeed, we found that SPG7, PPIF, and CCDC58 physically interact with each other and that several SARS-CoV-2 viral proteins, including M protein, ORF3a, ORF9b and 9C, ORF10 and NSP6, bind to mPTP complex proteins ( Figure 4 ) suggesting a likely involvement in COVID-19 induced mitochondrial dysfunction and cell death ( Figure 7 ). Since our results suggested that SARS-CoV-2 may alter mitochondrial morphology and function, we measured the effect of specific SARS-CoV-2 proteins on oxidative phosphorylation and mitochondrial calcium sequestration. Several of the proteins resulted in a substantial inhibition of maximal mitochondrial respiration and reduced the capacity of mitochondria to sequester calcium ( Figure 6 A-D). Cyclosporin A, which inhibits the mPTP, reversed these effects. These results suggest that SARS-CoV-2 proteins may alter the mPTP making it more prone to opening and triggering subsequent cell death. Consistent with this view, we found that infection of hiPSC-CMs with SARS-CoV-2 decreased cell viability and that this effect was reversed by cyclosporin A ( Figure  6F ).

Proper Ca 2+ dynamics are essential to cardiomyocyte function and any aberrations lead to cardiac pathological conditions (Bers, 2002 (Bers, , 2008 (Bers, , 2014 . The ER, mitochondria and plasma membranes all participate in the orchestration of calcium dynamics. In addition, to the perturbation of mitochondrial calcium sequestration (Figure 6 ), we noted that several transcripts involved in calcium transport, such as STIM1 and L-type calcium channels, were upregulated in COVID-19 PBMCs. To explore the effects of SARS-CoV-2 on cardiomyocyte calcium dynamics, we performed electrophysiologic studies on hi-PSC-CMs expressing SARS-CoV-2 proteins. The results show that these proteins dramatically disrupt the baseline oscillations of cell calcium and almost completely block L-type calcium channel activity indicating the cardiomyocyte damage and the development of heart failure.

In conclusion, our results show that SARS-CoV-2 proteins localize to mitochondria, bind to the mPTP complex, alter mitochondrial morphology and function, disrupt Ca 2+ cycling and inhibit VDCC channel activity, all indicating a perturbation of ion homeostasis and mitochondrial dysfunction (Figure 7) . These observations lead us to speculate that COVID-19 induced cardiac damage may be due to mitochondrial dysfunction. Moreover, these comprehensive analyses point towards new drug targets to preserve host cells against SARS-CoV-2 induced cardiac damage. Specifically, our results suggest that the mPTP blocker and immunosuppressive drug cyclosporin A may offer an additional therapeutic option to treat COVID-19 patients.

Although over 200 million people around the world are infected with coronavirus SARS-CoV-2, the causative agent of the COVID-19 pandemic, an understanding of the fundamental mechanisms underlying the clinical manifestation of COVID-19 is still emerging. Because of the nature of its infectivity, we were able to perform critical in vitro experiments with SARS-Co-V-2 virus. To understand the molecular nature and it host cellular distribution of the viral proteins, we utilized multiple cell models. Although it is considered as a limitation, our mRNA transcriptomics of human PBMCs and cellular and mitochondrial functional data are consistent and provide new insights into how viral protein components target mitochondria that elicits bioenergetic collapse and cardiomyocyte damage. 

All authors declare no competing interests. Vector or SARS-CoV-2 M-protein stably expressing HEK293 cells were permeabilized and exposed to boluses of 10 M Ca 2+ pulses with (C) or without (D) cyclosporin A (1 M) at the indicated time point.

(E) Quantification of mitochondrial CRC in both control and viral protein expressing conditions. Data are presented as the mean + SEM, n = 3-6 independent experiments. *P< 0.05, *P< 0.01, ***P<001. n.s., not significant.

(F) Assessment of cardiomyocyte viability following SARS-CoV-2 infection. hiPSCcardiomyocytes were challenged with virus at a MOI of one for 24 hours. After viral infections, were subjected to MTT assay to determine the viability. Data are presented as the mean + SEM, n = 4-8 independent experiments. *P< 0.01, n.s., not significant. 

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Muniswamy Madesh (muniswamy@uthscsa.edu).

This study did not generate new unique reagents.

 All data are included in the published article and the supplemental information files or are available from the lead contact upon request.

 This paper does not report original code.

 Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

This study was approved by the institutional review board of the University of Texas Southwestern Medical Center (IRB Protocol number STU-2020-0366).

A nasopharyngeal swab of suspected patients was subjected to real-time SARS-CoV-2 assay (m2000 Abbott) to confirm SARS-CoV-2 infection. SARS-CoV-2 infected patients with varying degrees of severity and uninfected patients were included in this study. For comparison, COVID-19 patients were stratified based on symptoms and the degree of medical care required during their respective hospital courses. Three groups of patients were identified: I) healthy volunteers, II) patients exhibiting mild to moderate COVID-19 associated respiratory disease, and III) severely affected patients presenting with critical COVID-19 manifestations requiring intensive medical intervention. The human subjects' details include sex and/or gender, age, and other additional details are provided in the table S1.

RNA was isolated from remnant clinical blood specimens collected from: I) Healthy volunteers, II) patients positive for SARS-CoV-2 with mild to moderate respiratory symptoms, and III) patients positive for SARS-CoV-2 requiring intensive care. Whole blood EDTA samples were centrifuged to remove the top plasma first before total RNA isolation from the remaining cell pellets. RNA-Seq was performed at GENEWIZ® (GENEWIZ, South Plainfield, NJ). Briefly, total RNA was processed for rRNA and globin depletion, quantified, and its integrity was confirmed prior to library construction using the NEBNext Ultra RNA Library Prep Kit (New England Biolabs, Ipswitch, MA). The sequencing libraries were multiplexed and sequenced on the Illumina HiSeq instrument using a 2x150 paired-end (PE) configuration. Image analysis and base calling were conducted by the HiSeq Control Software (HCS). Raw sequence data (.bcl files) generated from Illumina HiSeq were converted into fastq files and de-multiplexed using Illumina's bcl2fastq 2.17 software. One mismatch was allowed for index sequence identification. Using DESeq2, a comparison of gene expression between the groups of samples. Principal component analysis (PCA) was performed using the "plot PCA" function within the DESeq2 R package.

The iPSC line PENN123i-SV20 was used for generating hiPSC-CMs as previously described . The derivation of PENN123i-SV20 was approved by the Institutional Review Board of the University of Pennsylvania. hiPSC-CMs were infected with SARS-CoV-2 using a BSL-3 facility for 24 hrs, and various SARS-CoV-2 proteins (RFP-labeled constructs) were overexpressed using transient transfection methods. RNA was isolated from infected cells, and the expression of SARS-CoV-2 genes was confirmed using RT-PCR, followed by global RNA-Seq analysis. COS-7 (ATCC® CRL-1651), HeLa, HEK293 (ATCC® CRL-1573) and HEK293T (ATCC® CRL-3216) cells were cultured in high glucose (4.5g/L) DMEM (Hyclone, #SH30022) supplemented with 110 mg/L sodium pyruvate, 10% (v/v) FBS (Hyclone, #SH30396.03), and 1% (v/v) antibiotic-antimycotic solution. All cells were cultured at 37°C and 5% CO2. Trypsin (0.25% for COS-7 cells, 0.05%, for HEK cells) and TrypLE reagents for hiPSCs were used to detach cells from culture plates for experiments.

HeLa cells were plated on 30mm diameter, number 1.5 thickness coverslips coated with Poly-L-Lysine. Cells were co-transfected with CCDC58-Flag and Cox8a-mRFP using the FuGENE HD transfection reagent as per manufacturer instructions. After 24 hrs, cells were fixed with 4% paraformaldehyde for 15 min at room temperature (RT). Fixed cells were washed two-times with DPBS and permeabilized with 0.15% Triton X-100 solution for 15 min at RT. Permeabilized cells were blocked with 10% (w/v) bovine serum albumin (BSA) solution for 45 min at RT and subsequently incubated overnight with monoclonal anti-FLAG M2 antibody for the detection of CCDC58. After incubation, cells were washed three times with 10% BSA, and then the secondary anti-mouse Alexa 488 antibody was added for 1 hr at RT. After incubation with secondary antibody, cells were washed three times with Tris-buffered saline with 0.05% Tween 20 detergent (TBST) and imaged at LSM 510 META Confocal Laser Scanning Microscope (Carl Zeiss, Inc.) at 488-and 594nm excitations using a 40x oil objective. Co-localized pixels were quantified by detecting the fluorescence intensity of CCDC58-Flag and Cox8a-mRFP pixels using the line scan in ZEN blue software (Carl Zeiss, Inc.).

Ca 2+ flux analysis for the mitochondrial calcium retention capacity was performed as described earlier (Shanmughapriya et al., 2015a; Tomar et al., 2016) . Briefly, HeLa cells were trypsinized and washed in Ca 2+ and Mg 2+ free DPBS, and an equal number of cells (6x10 6 cells) were resuspended and permeabilized with 40 µg/ml digitonin in 1.5 ml of a Ca 2+ -free intracellular medium (ICM; 10 mM NaCl, 120 mM KCl, 1 mM KH2PO4, 20 mM HEPES-Tris, pH 7.2), supplemented with 2 µM thapsigargin to block the SERCA pump and 15 mM succinate. 1µM Fura-FF was added to the cell suspension for the detection of free bath Ca 2+ . Fura-FF fluorescence was monitored in a multiwavelength excitation dual-wavelength emission spectrofluorometer (Delta RAM, PTI, HORIBA). Bath Ca 2+ is shown as the [Ca 2+ ]out (µM). Ca 2+ boluses (10µM) were added until the mitochondria stopped clearing the Ca 2+ bolus, and then the mitochondrial uncoupler, FCCP (3 µM), was added to confirm mitochondrial depolarization. All Ca 2+ flux measurements were performed at 37°C with constant stirring.

HeLa, HEK293T, and COS-7 cells were cultured in 150 mm 2 cell culture dishes and transfected with CCDC58-Flag using the FuGENE HD transfection reagent per manufacturer instructions. Mitochondria were isolated by utilizing the mitochondria J o u r n a l P r e -p r o o f isolation kit for cultured cells (Abcam Cat# ab110170), as per manufacturer instructions. Total cell lysate (TCL) and cytosol (cyto) were collected, and the mitochondrial pellet was permeabilized with digitonin (0.2 mg/ml). After permeabilization, mitochondrial pellet and supernatant (sup) is collected. Trypsinization (Trypsin 0.1% w/v) of intact and permeabilized mitochondria was performed to validate the CCDC58 localization in mitochondrial compartments. Mitochondrial compartment-specific marker antibodies, TOM20 for outer mitochondrial membrane, Cytochrome c for intermembrane space, ATP5A for inner mitochondrial membrane, and PPIF for mitochondrial matrix were used.

hiPSC derived cardiomyocytes or COS-7 cells transiently transfected with the mRFPtagged SARS-CoV-2 plasmid constructs were grown on 25-mm 0.1% gelatin or collagen coated glass coverslips, respectively. 48 hours post-transfection, cells were loaded with 1 μM of ER Tracker blue-white DPX (ex/em 374/430 nm) and mitochondrial marker Dihydrorhodamine (2.5 μM; (ex/em 505/524 nm) in cell growth media for 30 minutes at 37°C (5% CO2). The cells were washed and imaged within a temperature-controlled environmental chamber set at 37°C using a Leica TCS SP8 live-cell confocal imaging system. The subcellular localization of the cells transfected with SARS-CoV-2 proteins was imaged using a 100x oil objective and analyzed using Leica Application Suite X. The colocalization of Cox-8a mRFP and the SARS-CoV-2 proteins (Vector control, M Protein, Orf9c, Orf3a, Nsp6, Nsp10) with the ER (ER BFP) and mitochondria (DHR 123) were quantitatively measured using the Leica Application Suite X. The levels of colocalization were plotted by calculating the Pearson's co-efficient of colocalization and overlap coefficient and the % of colocalization was determined. The values were plotted using GraphPad Prism version 8.

The mitochondrial phenotypic changes in cells infected with SARS-CoV-2 virus was evaluated using genetically encoded mitochondrial sensors and mitochondria staining dyes. hiPSC derived cardiomyocytes were grown on 25-mm gelatin-coated glass coverslips and were infected with Ad-mito-GCamp6 (ex/em 480/510 nm: MOI 5). After 48 h, the cells were infected with SARS-CoV-2 virus (MOI 1) for 24 h and fixed with 10% Neutral buffered formalin. The fixed cells were imaged on a Leica TCS SP8 confocal imaging system using a 100x oil objective. The levels of mitophagy and mitochondrial phenotype was imaged, and the mitochondrial length, area and perimeter were measured using the Leica Application Suite X. The results were tabulated and plotted using GraphPad Prism version 8.

hiPSC derived cardiomyocytes were grown on 25-mm gelatin-coated glass coverslips and were infected with SARS-CoV-2 virus (MOI 1) for 24 h and were stained with Mitotracker deep red FM (ex/em 644/665 nm) for 30 minutes. The stained cells were fixed with 10% Neutral buffered formalin. The fixed cells were imaged on a Leica TCS SP8 confocal imaging system using a 100x oil objective. The levels of mitophagy mitochondrial phenotype i.e., mitochondrial length, area and perimeter were measured using the Leica

Application Suite X. The results were tabulated and plotted using GraphPad Prism version 8.

To evaluate the suicidal effect of cells in response to the SARS-CoV-2 infection, hiPSC derived cardiomyocytes were infected with LC3 GFP/RFP tandem adenovirus (GFP ex/em 488/510 nm; RFP ex/em 552/584 nm; MOI 5). After 24 hrs, the cells were infected with SARS-CoV-2 (MOI 1) for 24 hrs and fixed with 10% neutral buffered formalin. The fixed cells were imaged on a Leica TCS SP8 imaging system using a 100x oil objective. The number of vesicular puncta were counted and plotted using GraphPad Prism version 8.

To visualize the ectopic localization of the SARS-CoV-2 viral proteins, hiPSC derived cardiomyocytes were infected with adenoviruses encoding tubulin-GFP (ex/em 484/507 nm; MOI 5) and Sec61 mCherry (Vector BioLabs, ex/em 587/610 nm; MOI 5). After 24 hrs, the cells were infected with SARS-CoV-2 virus (MOI 1) for 24 hrs and fixed with 10% neutral buffered formalin and imaged on a Leica TCS SP8 imaging system using a 100X oil objective. The phenotypic implications of the SARS-CoV-2 were analyzed using the Line Scan analysis, Leica Application Suite X.

HEK293T cells stably expressing negative shRNA, CCDC58 KD, or CCDC58-pBSD; as well as CCDC58 KD HEK293T cells stably expressing SARS-CoV-2 proteins (M Protein, Orf9c, Orf3a, Nsp6, Nsp7) or only expression vector, were used for the measurement of mitochondrial Ca 2+ uptake. Briefly, the cells were washed with Ca 2+ and Mg 2+ free DPBS, pH 7.4. An equal number of cells (~4-5x10 6 cells) were resuspended and permeabilized with 40 µg/ml digitonin in 1.5 mL ICM. Mitochondrial calcium uptake was measured in the presence of 1.5 mM Mg 2+ /ATP and 5 mM succinate, with or without 5 µM cyclosporin A (CsA). The permeabilized cells were loaded with Fura-2 FF (1 µM; ex 340/380 nm and em 510 nm). The measurement of extramitochondrial Ca 2+ clearance was used as an indicator of [Ca 2+ ]m uptake. Fluorescence was measured in a multi-wavelength excitation and dual-wavelength emission spectrofluorometer (Delta RAM, PTI, HORIBA). JC-1 (800 nM) was used simultaneous measurement of mitochondrial membrane potential. [Ca 2+ ]out is represented as the excitation ratio (ex/em 340/380 nm) of FURA2-FF/FA fluorescence and m as the ratio of fluorescence of J-aggregate (ex/em 570/595 nm) and monomer (ex/em 490/535 nm) forms of JC-1. Multiple Ca 2+ pulses (10 µM) and FCCP (10 µM) were added at the indicated time points. All the experiments were performed at 37°C with constant stirring (Mallilankaraman et al., 2012b; Tomar et al., 2019) .

Mitochondrial oxygen consumption rate COS-7 cells stably expressing the vector or the SARS-CoV-2 plasmid constructs (M Protein, Orf9c, Orf3a, Nsp6, Nsp7) as well as Neg shRNA and CCDC58 KD HEK293T cells were plated on 96 well Agilent Seahorse XF Cell Culture Microplates. The cells were plated at a density of 4 x 10 4 cells per well. Cells were cultured in the normal growth media overnight. Media was changed to Seahorse XF Cell Mito Stress Test Kit (Agilent) assay media supplemented with glucose, glutamine, pyruvate concentrations equivalent to that of the growth media 1 hour before the experiment start time. After media replacement, cells were placed in a CO2-free incubator for 1 hour. Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) was measured at 37°C in an XF96 extracellular flux analyzer (Seahorse Bioscience, Agilent), which had been previously calibrated using Seahorse XF Calibrant solution (Seahorse Bioscience, Agilent) in a CO2-free incubator overnight. Respiratory chain inhibitors were then loaded into the XF96 flux analyzer, and during the run, added sequentially to cells at indicated time points. The cells received oligomycin, FCCP, and a mixture of antimycin A and rotenone at concentrations of 2 µM, 2 µM, and 0.5 µM, respectively. Data was collected using Agilent Seahorse Wave 2.6.1 Desktop software and exported to GraphPad Prism version 8 for analysis Nemani et al., 2020) .

Human iPSC-CMs were grown on 0.1% gelatin-coated 25 mm glass coverslips. SARS-CoV-2 protein expressing hiPSC-CMs were loaded with Fluo-4/AM (5 μM, 30 min) in extracellular media at room temperature. Coverslips were mounted in a temperature controlled microincubator and imaged (Mallilankaraman et al., 2012b; Shanmughapriya et al., 2018) . Spontaneous Ca 2+ cycling was recorded every 3 seconds (TCS SP8 live cell imaging system, Leica, Wetzlar, Germany) at 488 nm excitations using a 100X oil objective. Images were analyzed and quantified by Leica application Suite X.

L-Type Ca 2+ current density recording L-type (ICa-L) calcium channel current was measured using whole-cell patch-clamp technique at room temperature. The whole-cell membrane currents were recorded using a low noise patch-clamp amplifier (Axopatch 200B; Axon Instruments, Hawthorn, Victoria, Australia) interfaced via a Digidata 1550B (Axon Instruments) to a PC running the pClamp 11 suite of software (Axon Instruments). All currents were filtered at 1 kHz. The currentvoltage curve was generated by voltage-clamp protocols consisting holding potential of -80 mV followed by a 3s long pre-pulse at -50 mV to inactivate Na + and T-type Ca 2+ channels, then a family of 300 ms depolarization from -50 mV to +60 mV in 10 mV increments. Patch pipettes were pulled from borosilicate glass capillaries (World Precision Instruments, Inc., Sarasota, Florida) using a model P-97 Flaming-Brown micropipette puller (Sutter Instrument Company, Novato, CA) and fire-polished on a micro-forge (MF-830; Narishige Scientific Instrument, Tokyo, Japan) to have a 3-5 MΩ when backfilled with the pipette (intracellular) solution. The pipette solution comprised (mM): CsCl (120), MgCl2 (3), EGTA (10), Mg 2+ /ATP (5), HEPES (5); pH was adjusted to 7.2 with CsOH. The bath (extracellular) solution comprised (mM): NaCl (14), CsCl (10), CaCl2 (1.8), MgCl2 (1), HEPES (10), 10 Glucose (10) and tetrodotoxin (0.01, TTX, TOCRIS, USA) to block Na + currents; pH was adjusted to 7.4 with NaOH. ICa-L was confirmed by its sensitivity to 10 µM of nifedipine. All chemicals were purchased from Sigma (Sigma-Aldrich, St. Louis, MO) unless noted otherwise.

To study the levels of mitochondrial ROS, Neg shRNA and CCDC58 KD HEK293T cells were grown on 25 mm collagen-coated glass coverslips overnight and loaded with the J o u r n a l P r e -p r o o f mitochondrial superoxide sensitive fluorophore MitoSOX red (ex/em 556/610 nm, 5 µM) for 30 min at 37°C. The stained cells were washed and imaged using a Leica SP8 confocal microscope, coupled with a temperature-controlled environmental chamber. The images were acquired and analyzed using the Zeiss LSM510 Meta NLO using ZEN2010 software (Mukopadhyay et al., 2007) .

HeLa neg shRNA and CCDC58 KD cells were treated with ionomycin (25 μM) for 6 h ± CsA (5 μM) or t-BH (100 μM) for 6 h ± CsA (1 M) and stained with PTP opening indicator calcein-AM. The reduction in fluorescence following treatments was assessed by confocal microscopy on comparison with the untreated controls (Shanmughapriya et al., 2015a) .

Cellular ATP levels were measured using CellTiter-Glo luminescent kit, and luminescence intensity was detected using the Infinite M1000 PRO plate reader (Tecan).

hiPSC-CMs were transiently transfected with mRFP/Flag-tagged SARS-CoV-2 plasmids construct individually. 48 hours post-transfection, cell lysates were prepared for Western blot analysis and SARS-CoV-2 viral protein expression was probed using FLAG antibody.

For immunoprecipitation, cell extracts were prepared using IP lysis buffer (ThermoFisher; 87788) containing protease and phosphatase inhibitor cocktail (ThermoFisher 78440). To assess the interaction of SARS-CoV-2 proteins with PPIF, SPG7 or CCDC58, FLAGtagged SARS-CoV-2 plasmid constructs were co-transfected with HA-tagged PPIF or HAtagged SPG7 or Myc-tagged CCDC58 plasmid in COS7 cells. Cell lysates were immunoprecipitated with HA for PPIF or SPG7 and with Myc for CCDC58. To determine the protein-protein interaction between SARS-CoV-2 proteins and PTP complex components, immunoprecipitated samples were probed with anti-FLAG antibody. To confirm the PPIF or SPG7 interaction with SARS-CoV-2 proteins, reverse immunoprecipitation was performed using anti-FLAG antibody and immunoprecipitated samples were probed with anti-HA antibody. To assess the CCDC58 binding with PPIF or SPG7, co-transfected lysates were immunoprecipitated with Myc. The whole-cell lysate and the eluate were probed with anti-Myc or anti-HA antibodies, respectively. To assess the interaction between SARS-CoV-2 proteins and endogenous SPG7 or ANT or ATP Synthase, FLAG-tagged SARS-CoV-2 plasmids transfected cell lysates were immunoprecipitated with anti-FLAG antibody and eluates were probed with either endogenous SPG7 or or ANT or ATP Synthase.

iPSC-CMs were plated on 0.1% gelatin coated 96-well plate. Cells were treated with cyclosporin-A (1 μM) prior to SARS-CoV-2 infection with 50 PFU for 24 hours. The cell viability was determined using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay according to the manufacturer protocol.

All data are expressed as mean ± SEM unless otherwise indicated. Statistical significance was evaluated using a Student's unpaired t-test for one or multiple samples, and one-way ANOVA followed by Tukey's multiple comparison test as needed with p < 0.05 considered to be statistically significant. Data from cells was obtained using built-in Leica software and were analyzed and plotted using GraphPad Prism version 8. Data S1: RNAseq analysis of PBMCs derived from SARS-CoV-2 infected patients with varying degrees of severity and uninfected human subjects. Related to Figures 1, 3, and 5 . In excel files, the "A" refers to uninfected subjects. The "B" refers to mild symptomatic SARS-CoV-2 infected patients. The "C" refers to severely affected SARS-CoV-2 patients.

Data S2: RNAseq analysis of iPSCs derived cardiomyocytes infected with SARS-CoV-2 virus. Related to Figure 7 . Supplemental files include differential splice variant expression data of control (M1, M2, and M3) and SARS-CoV-2 infected iPSCs (S1, S2, and S3). 

An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore

Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter

Calcium and cardiac rhythms: physiological and pathophysiological

Calcium cycling and signaling in cardiac myocytes

Cardiac sarcoplasmic reticulum calcium leak: basis and roles in cardiac dysfunction

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition

Markers of myocardial injury in the prediction of short-term COVID-19 prognosis

International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels

Host Calcium Channels and Pumps in Viral Infections

Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes

MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca

Lactate Elicits ER-Mitochondrial Mg(2+) Dynamics to Integrate Cellular Metabolism

A fortykilodalton protein of the inner membrane is the mitochondrial calcium uniporter

Mitochondrial Ca(2+) Uniporter Is a Mitochondrial Luminal Redox Sensor that Augments MCU Channel Activity

A Sialylated Voltage-Dependent Ca(2+) Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells

Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse

Dimers of mitochondrial ATP synthase form the permeability transition pore

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

HIV-1 Nef-induced cardiotoxicity through dysregulation of autophagy

Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study

SARS-CoV-2 Cell Entry J o u r n a l P r e -p r o o f Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Viral dependence on cellular ion channels -an emerging anti-viral target?

Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD

The mitochondrial calcium uniporter is a highly selective ion channel

MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism

MICU1 is an essential gatekeeper for MCU-mediated mitochondrial Ca(2+) uptake that regulates cell survival

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

Astrocytic metabolic switch is a novel etiology for Cocaine and HIV-1 Tat-mediated neurotoxicity

Mitochondrial pyruvate and fatty acid flux modulate MICU1-dependent control of MCU activity

A mitochondrial protein compendium elucidates complex I disease biology

The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter

SPG7 Is an Essential and Conserved Component of the Mitochondrial Permeability Transition Pore

FOXD1-dependent MICU1 expression regulates mitochondrial activity and cell differentiation

Dysregulation of mitochondrial bioenergetics and quality control by HIV-1 Tat in cardiomyocytes

Myocardial localization of coronavirus in COVID-19 cardiogenic shock

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies

MCUR1 Is a Scaffold Factor for the MCU Complex Function and Promotes Mitochondrial Bioenergetics

Blockade of MCU-Mediated Ca(2+) Uptake Perturbs Lipid Metabolism via PP4-Dependent AMPK Dephosphorylation

Viral proteins function as ion channels

Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients

Mitochondrial Permeability Uncouples Elevated Autophagy and Lifespan Extension

J o u r n a l P r e -p r o o f